Company intelligence / Profile preview

Population Health Partners

New York, New York, United Statespopulationhp.com ↗

Ownership: Private
Employees: ~25
Development stage: Phase 3

Overview

Population Health Partners is an active venture capital and private equity investment firm focused on building and supporting life science and healthcare technology companies that address prevalent and costly diseases. They leverage deep operational expertise from industry veterans to unlock value in biotechnology by investing across all company stages. Their approach bridges traditional VC/PE models with hands-on innovation management.

Therapeutic areas: PulmonologyEndocrinologyInfectious Diseases
Industry: Investors

Drug pipeline

2 assets

metformin

Phase 3

Indications: Type 2 diabetes with chronic kidney disease

1 more asset in the full pipeline.

Partnerships

ARCH Venture PartnersF-Prime CapitalGVMubadala CapitalNewpath PartnersSoftBank Vision Fund 2

Beyond the preview

Go deeper on Population Health Partners.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Population Health Partners.